Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2012
Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosisAaron E Miller, Paul O'Connor, Jerry S Wolinsky, et al.
Multiple Sclerosis and Related Disorders|May 31, 2016
Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life - A post hoc analysis of the TEMSO and TOWER studiesMathias Mäurer, Giancarlo Comi, Mark S Freedman, et al.
JAMA Neurology|November 25, 2014
Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for managementAnn M Arvin, Jerry S Wolinsky, Ludwig Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2023
Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx datasetMarcus W Koch, Ester Moral, Luis Brieva, et al.
Human Brain Mapping|June 23, 2015
Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort studyKoushik A Govindarajan, Sushmita Datta, Khader M Hasan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 4, 2023
Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trialGary Cutter, Richard A Rudick, Carl de Moor, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 29, 2023
Identifying the white matter pathways involved in multiple sclerosis-related tremor using diffusion tensor imagingAhmed Bayoumi, Khader M Hasan, Jorge Patino, et al.
Journal of Neurology|June 29, 2014
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER studyAaron E Miller, Richard Macdonell, Giancarlo Comi, et al.
Multiple Sclerosis and Related Disorders|February 10, 2016
Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensionsGiancarlo Comi, Mark S Freedman, Ludwig Kappos, et al.
Scientific Reports|July 26, 2024
Detection of diffusely abnormal white matter in multiple sclerosis on multiparametric brain MRI using semi-supervised deep learningBenjamin C Musall, Refaat E Gabr, Yanyu Yang, et al.
Pageof 14